Location History:
- Lausanne, SE (2003)
- Lausanne, CH (1993 - 2014)
Company Filing History:
3 out of 7 
1 out of 870 
1 out of 1 
Years Active: 1993-2014
Title: Giampietro Corradin: Innovator in Vaccine Development
Introduction
Giampietro Corradin is a notable inventor based in Lausanne, Switzerland. He has made significant contributions to the field of vaccine development, particularly in relation to malaria. With a total of 5 patents, his work focuses on enhancing immunogenicity and providing effective treatments for vulnerable populations.
Latest Patents
Corradin's latest patents include groundbreaking innovations such as a sub-region of a plasmodium protein with improved vaccine potential. This invention relates to a specific protein region that shows promise for the treatment and diagnosis of malaria. The polypeptides derived from the PFF0165c protein of 3D7 exhibit high antigenicity and immunogenicity, demonstrating strong clinical protection against malaria, especially for infants, toddlers, children under the age of 5, and pregnant women. Another significant patent involves an immunological response potentiation process for synthetic or genetically engineered antigens with low immunogenicity. This process utilizes biodegradable microparticles to enhance the immune response, making it effective for immunizing against various diseases.
Career Highlights
Throughout his career, Giampietro Corradin has worked with esteemed organizations such as Rmf Dictagene S.A. and Institut Pasteur. His experience in these institutions has allowed him to develop innovative solutions in the field of immunology and vaccine research.
Collaborations
Corradin has collaborated with notable individuals in the field, including Pierre Druilhe and Ali Jafarshad. These partnerships have contributed to the advancement of his research and the development of effective vaccine strategies.
Conclusion
Giampietro Corradin's contributions to vaccine development, particularly in malaria treatment, highlight his role as an influential inventor. His innovative patents and collaborations continue to pave the way for advancements in immunology and public health.